Clinico - pathological correlation of hormone receptors and human epidermal growth factor receptor (HER2/neu) with axillary lymph node involvement in females with early cancer breast /
Sherif Mohamed Ali Mokhtar
Clinico - pathological correlation of hormone receptors and human epidermal growth factor receptor (HER2/neu) with axillary lymph node involvement in females with early cancer breast / العلاقة الإكلينيكية - الباثولوجية بين مستقبلات الهرمونات وهير-2 وبين الإصابة السرطانية للعقد الليمفاوية الإبطية فى مريضات سرطان الثدى المبكر Sherif Mohamed Ali Mokhtar : Supervised Mostafa Lotfy Aboelnasr , Sayed Ahmed Marie , Ali Ahmed Elhindawy - Cairo : Sherif Mohamed Ali Mokhtar , 2010 - 212 P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of General Surgery
In women with early breast cancer (stage I , stage II) the tumor expression of HER2/neu and hormone receptors (ER , PR) which are emerging prognostic factors could not be related to the axillary lymph node status whether positive or negative node table (II) . And this is consistent with the clinical observations in the literature
Early females breast cancer ER , PR receptors HER2 / neu
Clinico - pathological correlation of hormone receptors and human epidermal growth factor receptor (HER2/neu) with axillary lymph node involvement in females with early cancer breast / العلاقة الإكلينيكية - الباثولوجية بين مستقبلات الهرمونات وهير-2 وبين الإصابة السرطانية للعقد الليمفاوية الإبطية فى مريضات سرطان الثدى المبكر Sherif Mohamed Ali Mokhtar : Supervised Mostafa Lotfy Aboelnasr , Sayed Ahmed Marie , Ali Ahmed Elhindawy - Cairo : Sherif Mohamed Ali Mokhtar , 2010 - 212 P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of General Surgery
In women with early breast cancer (stage I , stage II) the tumor expression of HER2/neu and hormone receptors (ER , PR) which are emerging prognostic factors could not be related to the axillary lymph node status whether positive or negative node table (II) . And this is consistent with the clinical observations in the literature
Early females breast cancer ER , PR receptors HER2 / neu